Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Clinical Trials Using Actinium Ac 225 Lintuzumab

Review the clinical trials studying actinium ac 225 lintuzumab on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-3 of 3

Testing an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients with High-Risk Myelodysplastic Syndrome That Has Not Responded to Other Treatment
Status: Active
Location: Dana-Farber - Harvard Cancer Center LAO, Boston, Massachusetts
Testing the Combination of Targeted Radiotherapy with Anti-Cancer Drugs, Venetoclax and ASTX-727, to Improve Outcomes for Adults with Newly Diagnosed Acute Myeloid Leukemia
Status: Active
Location: Yale University Cancer Center LAO, New Haven, Connecticut
Venetoclax and Lintuzumab-Ac225 in AML Patients
Status: Active
Location: See ClinicalTrials.gov